Pfizer is investing heavily in research and development to overcome these challenges. The company collaborates with academic institutions, biotech firms, and regulatory bodies to ensure the safe and effective use of nanotechnology in its products. Continuous advancements in nanomaterials science and the development of new, innovative delivery systems are part of Pfizer’s strategy to address these hurdles.
